Tizanidine, a muscle relaxant, is primarily used to handle spasticity. Commonplace drug screenings sometimes don’t embody checks particularly designed to detect its presence. Consequently, a routine drug check panel is unlikely to disclose its utilization.
The absence of tizanidine from widespread drug check panels stems from a number of components. These embody the comparatively low potential for abuse in comparison with different managed substances, in addition to the fee and complexity related to creating and implementing particular assays. Traditionally, drug testing has targeted on substances with increased charges of misuse and dependence.
